Risk factors for nonvisualization of the sentinel lymph node on lymphoscintigraphy in breast cancer patients by Youssef Chahid, Xinbo Qiu, Ewoudt M. W. van de Garde, Hein J. Verberne, Jan Booij

Get full text

Differential metabolic host response to pathogens associated with community-acquired pneumonia by Ilona den Hartog, Naama Karu, Laura B. Zwep, G. Paul Voorn, Ewoudt M.W. van de Garde, Thomas Hankemeier, J.G. Coen van Hasselt

Get full text

Latent class analysis-based subgroups and response to corticosteroids in hospitalised community-acquired pneumonia patients: a validation study by Esther Wittermans, Philip A. van der Zee, Hongchao Qi, Jan C. Grutters, G. Paul Voorn, Willem Jan W. Bos, Ewoudt M.W. van de Garde, Henrik Endeman

Get full text

Inter-hospital variation in the utilization of diagnostics and their proportionality in the management of adult community-acquired pneumonia by Stefan M. T. Vestjens, Esther Wittermans, Simone M. C. Spoorenberg, Jan C. Grutters, Charlotte A. van Ruitenbeek, G. Paul Voorn, Willem Jan W. Bos, Ewoudt M. W. van de Garde

Get full text

Consecutive antibiotic use in the outpatient setting: an extensive, longitudinal descriptive analysis of antibiotic dispensing data in the Netherlands by Loek A. W. de Jong, Paul D. van der Linden, Monique M. B. Roukens, Ewoudt M. W. van de Garde, Alike W. van der Velden, Stephanie Natsch, on behalf of SWAB’s Working Group on Surveillance of Antimicrobial Use

Get full text

Metabolomic profiling of microbial disease etiology in community-acquired pneumonia. by Ilona den Hartog, Laura B Zwep, Stefan M T Vestjens, Amy C Harms, G Paul Voorn, Dylan W de Lange, Willem J W Bos, Thomas Hankemeier, Ewoudt M W van de Garde, J G Coen van Hasselt

Get full text

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands by Christine M. Cramer-van der Welle, Marjon V. Verschueren, Merel Tonn, Bas J. M. Peters, Franz M. N. H. Schramel, Olaf H. Klungel, Harry J. M. Groen, Ewoudt M. W. van de Garde, The Santeon NSCLC Study Group

Get full text

Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands by Zakile A. Mfumbilwa, Janneke A. Wilschut, Martijn J. H. G. Simons, Bram Ramaekers, Manuela Joore, Valesca Retèl, Christine M. Cramer-van der Welle, Franz M. N. H. Schramel, Ewoudt M. W. van de Garde, Veerle M. H. Coupé

Get full text

Real-world palbociclib effectiveness in patients with metastatic breast cancer: Focus on neutropenia-related treatment modification strategies and clinical outcomes by Mariska Q.N. Hackert, Cornelia F. van Uden-Kraan, Mariette J. Agterof, Annette W.G. van der Velden, Birgit E.P.J. Vriens, Johan J.B. Janssen, Maud Geenen, Annemieke van der Padt-Pruijsten, Ewoudt M.W. van de Garde

Get full text